1.
|
原著(症例報告除く)
|
Two isoforms of cyclic GMP-dependent kinase-I exhibit distinct expression patterns in the adult mouse dorsal root ganglion. 2018/08
|
2.
|
原著(症例報告除く)
|
Development of a novel photoaffinity probe for labeling nocistatin receptor. 2018/06
|
3.
|
原著(症例報告除く)
|
Impaired peripheral nerve regeneration in type-2 diabetic mouse model. 2018/01
|
4.
|
原著(症例報告除く)
|
Developmental origin of long-range neurons in the superficial dorsal spinal cord 2017/11
|
5.
|
原著(症例報告除く)
|
Na+ /K+ -ATPase coupled to endothelin receptor type B stimulates peripheral nerve regeneration via lactate signalling 2017/09
|
6.
|
原著(症例報告除く)
|
RNA editing enzyme ADAR2 is a mediator of neuropathic pain after peripheral nerve injury 2017/05
|
7.
|
原著(症例報告除く)
|
Expression of hOvol2 in the XY body of human spermatocytes 2017/02
|
8.
|
原著(症例報告除く)
|
Conserved role of Ovo in germline development in mouse and Drosophila 2017/01
|
9.
|
原著(症例報告除く)
|
Microscopic visualization of testosterone in mouse testis by use of imaging mass spectrometry 2016/11
|
10.
|
原著(症例報告除く)
|
Involvement of Brain-Enriched Guanylate Kinase-Associated Protein (BEGAIN) in Chronic Pain after Peripheral Nerve Injury 2016/10
|
11.
|
原著(症例報告除く)
|
Phosphorylation of NMDA receptor GluN2B submit as its Tyr1472 is important for trigeminal processing of itch 2016/10
|
12.
|
原著(症例報告除く)
|
Elucidation of the mechanism of suppressed steroidogenesis during androgen deprivation therapy of prostate cancer patients using a mouse model 2016/09
|
13.
|
原著(症例報告除く)
|
Intrathecal administration of low-dose nociceptin/orphanin FQ induces allodynia via c-Jun N-terminal kinase and monocyte chemoattractant protein-1 2016/06
|
14.
|
原著(症例報告除く)
|
Involvement of NIPSNAP1, a neuropeptide nocistatin-interacting protein, in inflammatory pain 2016/03
|
15.
|
原著(症例報告除く)
|
Role of c-Jun N-terminal kinase in late nerve regeneration monitored by in vivo imaging of thy1-yellow fluorescent protein transgenic mice 2016/02
|
16.
|
原著(症例報告除く)
|
Comparison of mechanisms of allodynia induced by acromelic acid A between early and late phases 2015/08
|
17.
|
原著(症例報告除く)
|
In vivo two-photon imaging of structural dynamics in the spinal dorsal horn in an inflammatory pain model 2015/04
|
18.
|
総説
|
Nocistatin: milestone of one decade of research 2015/02
|
19.
|
総説
|
Pain regulation by nocistatin-targeting molecules: G protein-coupled-receptor and nocistatin-interacting protein 2015
|
20.
|
原著(症例報告除く)
|
Three-dimensional distribution of sensory stimulation-evoked neuronal activity of spinal dorsal horn neurons analyzed by in vivo calcium imaging 2014/08
|
21.
|
原著(症例報告除く)
|
Transcriptional mechanisms link epithelial plasticity to adhesion and differentiation of epidermal progenitor cells 2014/04
|
22.
|
原著(症例報告除く)
|
Controllable urokinase gene expression in trabecular meshwork cells. 2014/03
|
23.
|
原著(症例報告除く)
|
Involvement of Nax sodium channel in peripheral nerve regeneration via lactate signaling. 2014/03
|
24.
|
原著(症例報告除く)
|
Identification of nitrated tyrosine residues of protein kinase G-Iα by mass spectrometry. 2014/02
|
25.
|
原著(症例報告除く)
|
The small cell lung cancer-specific isoform of RE1-silencing transcription factor (REST) is regulated by neural-specific Ser/Arg repeat-related protein of 100 kDa (nSR100). 2013/10
|
26.
|
総説
|
神経科学領域における質量分析イメージング 2013/10
|
27.
|
原著(症例報告除く)
|
The action site of the synthetic kainoid (2S,3R,4R)-3-carboxymethyl-4-(4-methylphenylthio)pyrrolidine-2-carboxylic acid (PSPA-4), an analogue of Japanese mushroom poison acromelic acid, for allodynia (tactile pain 2013/06
|
28.
|
原著(症例報告除く)
|
SCRAPPER Regulates the Thresholds of Long-Term Potentiation/Depression, the Bidirectional Synaptic Plasticity in Hippocampal CA3-CA1 Synapses. 2012/12
|
29.
|
原著(症例報告除く)
|
Proteomic analysis of cerebrospinal fluid before and after intrathecal injection of steroid into patients with postherpetic pain. 2012/10
|
30.
|
原著(症例報告除く)
|
Involvement of Tyr1472 phosphorylation of NMDA receptor NR2B subunit in postherpetic neuralgia in model mice. 2012/08
|
31.
|
原著(症例報告除く)
|
Visualization of acetylcholine distribution in central nervous system tissue sections by tandem imaging mass spectrometry. 2012/07
|
32.
|
原著(症例報告除く)
|
Novel Strategy for the Control of Postoperative Pain: Long-Lasting Effect of an Implanted Analgesic Hydrogel in a Rat Model of Postoperative Pain. 2012/06
|
33.
|
原著(症例報告除く)
|
Identification of NIPSNAP1 as a Nocistatin-interacting Protein Involving Pain Transmission. 2012/03
|
34.
|
原著(症例報告除く)
|
Restricted Expression of Ovol2/MOVO in XY Body of Mouse Spermatocytes at the Pachytene Stage. 2012/03
|
35.
|
原著(症例報告除く)
|
Identification of oligosaccharides from histopathological sections by MALDI imaging mass spectrometry. 2012/02
|
36.
|
総説
|
ニューロペプチド—update 痛み ノシセプチンとノシスタチン 2012/02
|
37.
|
原著(症例報告除く)
|
Rapid S-nitrosylation of actin by NO-generating donors and in inflammatory pain model mice. 2011/12
|
38.
|
総説
|
医薬品開発のためのペインクリニックの現状 2011/06
|
39.
|
総説
|
医薬品開発のための慢性疼痛発生・維持機構の考え方 2011/05
|
40.
|
総説
|
痛みとしびれのサイエンス-基礎と臨床 第1章:痛み,しびれのメカニズム, 痛みの可塑性と慢性化 2011/05
|
41.
|
原著(症例報告除く)
|
Synthesis of an acromelic acid A analog-based (11)C-labeled PET tracer for exploration of the site of action of acromelic acid A in allodynia induction. 2011/04
|
42.
|
原著(症例報告除く)
|
Induction of arginase II mRNA by nitric oxide using in vitro model of gyrate atrophy of choroid and retina. 2011/03
|
43.
|
原著(症例報告除く)
|
Involvement of spinal phosphorylation cascade of Tyr1472-NR2B, Thr286-CaMKII, and Ser831-GluR1 in neuropathic pain. 2011/03
|
44.
|
原著(症例報告除く)
|
Reversal of Inducible Nitric Oxide Synthase Uncoupling Unmasks Tolerance to Ischemia/Reperfusion Injury in the Diabetic Rat Heart. 2011/03
|
45.
|
原著(症例報告除く)
|
A novel role of prostaglandin E2 in neuropathic pain: blockade of microglial migration in the spinal cord. 2011/02
|
46.
|
原著(症例報告除く)
|
Synaptic E3 Ligase SCRAPPER in Contextual Fear Conditioning: Extensive Behavioral Phenotyping of Scrapper Heterozygote and Overexpressing Mutant Mice. 2011/02
|
47.
|
原著(症例報告除く)
|
Characterization of nestin expression in the spinal cord of GFP transgenic mice after peripheral nerve injury. 2010/10
|
48.
|
原著(症例報告除く)
|
Impairment of CaMKII activation and attenuation of neuropathic pain in mice lacking NR2B phosphorylated at Tyr1472. 2010/09
|
49.
|
原著(症例報告除く)
|
Novel cis-active structures in the coding region mediate CRM1-dependent nuclear export of IFN-α 1 mRNA. 2010/09
|
50.
|
その他
|
Dexamethasone inhibits the induction of inos gene expression through destabilization of its mrna in proinflammatory cytokine-stimulated hepatocytes 2010/01
|
51.
|
その他
|
脳回転状脈絡網膜萎縮症の網膜色素上皮細胞におけるアルギナーゼⅡの役割 2010/01
|
52.
|
原著(症例報告除く)
|
Involvement of prostaglandin F2α receptor in ATP-induced mechanical allodynia 2009/09
|
53.
|
原著(症例報告除く)
|
Involvement of S-nitrosylation of actin in inhibition of neurotransmitter release by nitric oxide. 2009/09
|
54.
|
総説
|
脊髄における痛みの伝達機構 2009/08
|
55.
|
原著(症例報告除く)
|
Translocation of neuronal nitric oxide synthase to the plasma membrane by ATP is mediated by P2X and P2Y receptors 2009/07
|
56.
|
原著(症例報告除く)
|
Effects of neurotrophic factors on nerve regeneration monitored by in vivo imaging in thy1-YFP transgenic mice. 2009/04
|
57.
|
総説
|
【神経障害性疼痛の基礎と臨床】 神経障害性疼痛に関する基礎研究 慢性疼痛研究の最近の進歩 機能的変化による慢性疼痛の維持機構 2009/04
|
58.
|
総説
|
細胞内トラッフィキングによる一酸化窒素合成酵素の活性化機構の解明 2009/02
|
59.
|
原著(症例報告除く)
|
Functional restoration of rabbit spinal cord using collagen-filament scaffold 2009/01
|
60.
|
原著(症例報告除く)
|
Edaravone inhibits the induction of iNOS gene expression at transcriptional and posttranscriptional steps in murine macrophages. 2008/12
|
61.
|
原著(症例報告除く)
|
Characterization of signaling pathway for the translocation of neuronal nitric oxide synthase to the plasma membrane by PACAP. 2008/06
|
62.
|
原著(症例報告除く)
|
Involvement of stem cell factor and its receptor tyrosine kinase c-kit in pain regulation. 2008/06
|
63.
|
原著(症例報告除く)
|
N-ethylmaleimide-sensitive fusion protein (NSF) is involved in central sensitization in the spinal cord through GluR2 subunit composition switch after inflammation 2008/06
|
64.
|
総説
|
【痛みのメカニズムとその制御】 痛みにおけるNOの関与 2008/05
|
65.
|
原著(症例報告除く)
|
疼痛治療の新しいアプローチ 局所麻酔薬と侵害受容器 2008/04
|
66.
|
原著(症例報告除く)
|
Edaravone prevents iNOS expression by inhibiting its promoter transactivation and mRNA stability in cytokine-stimulated hepatocytes. 2008/03
|
67.
|
原著(症例報告除く)
|
Studies on membrane-associated prostaglandin E synthase-2 with reference to production of 12L-hydroxy-5,8,10-heptadecatrienoic acid (HHT) 2008/03
|
68.
|
総説
|
アクロメリン酸と痛み 2008/03
|
69.
|
原著(症例報告除く)
|
Na(+)/H(+) exchanger inhibitor, FR183998, has protective effect in lethal acute liver failure and prevents iNOS induction in rats. 2008/02
|
70.
|
原著(症例報告除く)
|
Natural antisense transcript stabilizes inducible nitric oxide synthase messenger RNA in rat hepatocytes 2008/02
|
71.
|
原著(症例報告除く)
|
Pitavastatin up-regulates the induction of iNOS through enhanced stabilization of its mRNA in pro-inflammatory cytokine-stimulated hepatocytes. 2008/02
|
72.
|
原著(症例報告除く)
|
Rebamipide, anti-gastric ulcer drug, up-regulates the induction of iNOS in proinflammatory cytokine-stimulated hepatocytes. 2008/02
|
73.
|
原著(症例報告除く)
|
Molecular characterization of a novel type of prostamide/prostaglandin F synthase, belonging to the thioredoxin-like superfamily 2008/01
|
74.
|
原著(症例報告除く)
|
A synthetic kainoid, (2S,3R,4R)-3-carboxymethyl-4-(phenylthio)pyrrolidine-2-carboxylic acid (PSPA-1) serves as a novel anti-allodynic agent for neuropathic pain. 2007/12
|
75.
|
原著(症例報告除く)
|
Different roles of nitric oxide synthase-1 and -2 between herpetic and postherpetic allodynia in mice. 2007/12
|
76.
|
原著(症例報告除く)
|
プロスタグランジンとノシセプチン 2007/11
|
77.
|
総説
|
脊髄後角におけるNMDA受容体リン酸化と神経因性疼痛 2007/11
|
78.
|
原著(症例報告除く)
|
【泌尿器科疼痛対策】 痛覚の発生機序の最前線 2007/10
|
79.
|
原著(症例報告除く)
|
Characterization of alternatively spliced isoforms of the type I interleukin-1 receptor on iNOS induction in rat hepatocytes. 2007/09
|
80.
|
原著(症例報告除く)
|
Effect of thiol-containing molecule cysteamine on the induction of inducible nitric oxide synthase in hepatocytes. 2007/09
|
81.
|
原著(症例報告除く)
|
Nitric oxide (NO) serves as a retrograde messenger to activate neuronal NO synthase in the spinal cord via NMDA receptors. 2007/08
|
82.
|
原著(症例報告除く)
|
Polyamines upregulate the mRNA expression of cationic amino acid transporter-1 in human retinal pigment epithelial cells. 2007/08
|
83.
|
原著(症例報告除く)
|
Ovol2/Movo, a homologue of Drosophila ovo, is required for angiogenesis, heart formation and placental development in mice. 2007/06
|
84.
|
原著(症例報告除く)
|
Senescence in cultured trabecular meshwork cells. 2007/06
|
85.
|
原著(症例報告除く)
|
Signal pathways coupled to activation of neuronal nitric oxide synthase in the spinal cord by nociceptin/orphanin FQ. 2007/04
|
86.
|
総説
|
【シナプス後部構造の形成・機構と制御】 シナプス後肥厚部のNMDA受容体のリン酸化と神経因性疼痛 2007/04
|
87.
|
原著(症例報告除く)
|
慢性疼痛の発生維持機構について 2007/04
|
88.
|
原著(症例報告除く)
|
Interleukin-1 is not essential for expression of inducible NOS in hepatocytes induced by lipopolysaccharide in vivo. 2007/03
|
89.
|
総説
|
慢性疼痛研究の最近の進歩 機能的変化による慢性疼痛の維持機構 2007/02
|
90.
|
原著(症例報告除く)
|
Cytotoxic effect of spermine on retinal pigment epithelial cells. 2007/01
|
91.
|
原著(症例報告除く)
|
Ornithine transport via cationic amino acid transporter-1 is involved in ornithine cytotoxicity in retinal pigment epithelial cells. 2007/01
|
92.
|
総説
|
アロディニアのメカニズムとその制御 2006/09
|
93.
|
総説
|
【痛みの研究最前線】 脊髄におけるノシセプチン/オーファニンFQを介したプロスタグランジンによる疼痛制御ネットワーク 2006/05
|
94.
|
原著(症例報告除く)
|
In situ measurement of neuronal nitric oxide synthase activity in the spinal cord by NADPH-diaphorase histochemistry. 2006/01
|
95.
|
原著(症例報告除く)
|
Proteomic identification of a novel isoform of collapsin response mediator protein-2 in spinal nerves peripheral to dorsal root ganglia. 2006
|
96.
|
原著(症例報告除く)
|
The opioid peptide nociceptin/orphanin FQ mediates prostaglandin E 2-induced allodynia, tactile pain associated with nerve injury 2006
|
97.
|
総説
|
【RSD(CRPS-type 1)の病態・診断・治療】 病態 治療のための疼痛の分子メカニズム 2006
|
98.
|
総説
|
【痛み】 痛みの測定・評価法 痛みの生化学的評価 バイオマーカー探索の試み 2006
|
99.
|
総説
|
【薬理学における痛み研究の新しい潮流】 痛み研究への誘い 脊髄における一酸化窒素(NO)産生と痛み 2006
|
100.
|
原著(症例報告除く)
|
Rho-kinase mediates spinal nitric oxide formation by prostaglandin E2 via EP3 subtype. 2005/12
|
101.
|
総説
|
プロスタグランジン受容体の機能・多様性と痛み機構 2005/12
|
102.
|
原著(症例報告除く)
|
Fyn kinase-mediated phosphorylation of NMDA receptor NR2B subunit at Tyr1472 is essential for maintenance of neuropathic pain. 2005/09
|
103.
|
原著(症例報告除く)
|
Cytoprotection by nipradilol, an anti-glaucomatous agent, via down-regulation of apoptosis related gene expression and activation of NF-kappaB. 2005
|
104.
|
原著(症例報告除く)
|
Involvement of Rho-kinase in inflammatory and neuropathic pain through phosphorylation of myristoylated alanine-rich C-kinase substrate (MARCKS). 2005
|
105.
|
原著(症例報告除く)
|
Preemptive analgesia by zaltoprofen that inhibits bradykinin action and cyclooxygenase in a post-operative pain model. 2005
|
106.
|
総説
|
アロディニアの発現と抑制 2005
|
107.
|
総説
|
プロスタノイドと痛み 2005
|
108.
|
原著(症例報告除く)
|
Analgesic effect of extracts of Chinese medicinal herbs Moutan cortex and Coicis semen on neuropathic pain in mice. 2004/11
|
109.
|
原著(症例報告除く)
|
Membrane-associated prostaglandin E synthase-1 is required for neuropathic pain. 2004/06
|
110.
|
原著(症例報告除く)
|
A simple acromelic acid analog potentially useful for receptor photoaffinity labeling and biochemical studies. 2004
|
111.
|
原著(症例報告除く)
|
Acute and late effects on induction of allodynia by acromelic acid, a mushroom poison related structurally to kainic acid. 2004
|
112.
|
原著(症例報告除く)
|
Characterization of N-methyl-D-aspartate receptor subunits involved in acute ammonia toxicity. 2004
|
113.
|
原著(症例報告除く)
|
Characterization of N-methyl-D-aspartate receptor subunits responsible for postoperative pain. 2004
|
114.
|
原著(症例報告除く)
|
Characterization of the isoforms of MOVO zinc finger protein, a mouse homologue of Drosophila Ovo, as transcription factors. 2004
|
115.
|
原著(症例報告除く)
|
Cycloprodigiosin up-regulates inducible nitric oxide synthase gene expression in hepatocytes stimulated by interleukin-1beta. 2004
|
116.
|
原著(症例報告除く)
|
Epidermal growth factor and interleukin-1beta synergistically stimulate the production of nitric oxide in rat intestinal epithelial cells. 2004
|
117.
|
原著(症例報告除く)
|
Further evidence that epidermal growth factor enhances the intestinal adaptation following small bowel transplantation. 2004
|
118.
|
原著(症例報告除く)
|
Monitoring for dynamic biological processing by intramolecular bioluminescence resonance energy transfer system using secreted luciferase. 2004
|
119.
|
原著(症例報告除く)
|
Pirfenidone inhibits the induction of iNOS stimulated by interleukin-1beta at a step of NF-kappaB DNA binding in hepatocytes. 2004
|
120.
|
原著(症例報告除く)
|
Pituitary adenylate cyclase-activating polypeptide is required for the development of spinal sensitization and induction of neuropathic pain. 2004
|
121.
|
原著(症例報告除く)
|
Synthesis of prostaglandin F ethanolamide by prostaglandin F synthase and identification of Bimatoprost as a potent inhibitor of the enzyme: new enzyme assay method using LC/ESI/MS. 2004
|
122.
|
原著(症例報告除く)
|
Up-regulation of IL-1 receptor through PI3K/Akt is essential for the induction of iNOS gene expression in hepatocytes. 2004
|
123.
|
総説
|
【痛みの分子メカニズムと臨床 基礎研究と治療の最前線】 プロスタノイドの痛覚における役割 2004
|
124.
|
総説
|
【痛みシグナルの制御機構と最新治療エビデンス】 疼痛の生理機構と分子メカニズム ノシセプチンの疼痛制御 2004
|
125.
|
総説
|
片頭痛の発現機構 片頭痛発作時にアロディニアが惹起される 2004
|
126.
|
原著(症例報告除く)
|
Analyses of dendritic cell subsets in pregnancy. 2003
|
127.
|
原著(症例報告除く)
|
Asymmetric reduction of benzil to (S)-benzoin with whole cells of Bacillus cereus. 2003
|
128.
|
原著(症例報告除く)
|
Attenuation of neuropathic pain by the nociceptin/orphanin FQ antagonist JTC-801 is mediated by inhibition of nitric oxide production. 2003
|
129.
|
原著(症例報告除く)
|
Characterrization of N-methyl-D-asparate receptor subunits involved in acute ammonia toxicity 2003
|
130.
|
原著(症例報告除く)
|
Expression of 20alpha-hydroxysteroid dehydrogenase mRNA in human endometrium and decidua. 2003
|
131.
|
原著(症例報告除く)
|
Functional characterization of prostaglandin F2alpha receptor in the spinal cord for tactile pain (allodynia). 2003
|
132.
|
原著(症例報告除く)
|
Functional evidence for interaction between prostaglandin EP3 and kappa-opioid receptor pathways in tactile pain induced by human immunodeficiency virus type-1 (HIV-1) glycoprotein gp120. 2003
|
133.
|
原著(症例報告除く)
|
Prevention of ornithine cytotoxicity by nonpolar side chain amino acids in retinal pigment epithelial cells. 2003
|
134.
|
総説
|
病態としての"痛み"研究】 脊髄のPGsと痛み 2003
|
135.
|
原著(症例報告除く)
|
Altered response to inflammatory cytokines in hepatic energy metabolism in inducible nitric oxide synthase knockout mice. 2002
|
136.
|
原著(症例報告除く)
|
Central nociceptive role of prostacyclin (IP) receptor induced by peripheral inflammation. 2002
|
137.
|
原著(症例報告除く)
|
Characterization of nociceptin/orphanin FQ-induced pain responses by the novel receptor antagonist N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl) benzamide monohydrochloride. 2002
|
138.
|
原著(症例報告除く)
|
Effect of epidermal growth factor on intestinal adaptation after allogeneic small bowel transplantation in rats. 2002
|
139.
|
原著(症例報告除く)
|
Effect of epidermal growth factor on intestinal adaptation after allogeneic small bowel transplantation in rats. 2002
|
140.
|
原著(症例報告除く)
|
Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. 2002
|
141.
|
原著(症例報告除く)
|
Pain transmission regulated by novel neuropeptides nocistatin and nociceptin/orphanin FQ. 2002
|
142.
|
原著(症例報告除く)
|
The enzymes with benzil reductase activity conserved from bacteria to mammals. 2002
|
143.
|
原著(症例報告除く)
|
The human transcription factor activation protein-2 gamma (AP-2gamma): gene structure, promoter, and expression in mammary carcinoma cell lines. 2002
|
144.
|
その他
|
神経因性疼痛の分子機構 2002
|
145.
|
総説
|
生化学の立場からみた痛みの分子機構と治療 2002
|
146.
|
総説
|
Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin. 2001
|
147.
|
原著(症例報告除く)
|
Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice. 2001
|
148.
|
原著(症例報告除く)
|
Characterization of the glutamatergic system for induction and maintenance of allodynia. 2001
|
149.
|
原著(症例報告除く)
|
Effects of amino acids on the amidation of polyaromatic carboxylic acids by Bacillus cereus. 2001
|
150.
|
原著(症例報告除く)
|
Isolation and expression of a Bacillus cereus gene encoding benzil reductase. 2001
|
151.
|
原著(症例報告除く)
|
Platelet-activating factor acetylhydrolase iso-forms I and II in human uterus. Comparisons with pregnant uterus and myoma. 2001
|
152.
|
原著(症例報告除く)
|
The effects of capsaicin cream on prostaglandin-induced allodynia. 2001
|
153.
|
総説
|
【ペインコントロール 癌及び非癌性疼痛緩和研究の進歩】 慢性疼痛のメカニズム 2001
|
154.
|
原著(症例報告除く)
|
医学部3年次の画像処理演習-意義,方法,学生からの評価 2001
|
155.
|
総説
|
基礎麻酔学セミナー 脊髄における痛みの伝達機構 2001
|
156.
|
総説
|
痛みの可塑性 2001
|
157.
|
総説
|
【痛みとその制御機構 分子メカニズムと治療の最前線】 疼痛の生理機構と分子メカニズム アロディニアのメカニズム 2000/12
|
158.
|
総説
|
【感覚受容の分子機構を探る 嗅・味・痛覚の受容体研究と医学応用への可能性】 痛みの分子機構と医学への応用 2000/11
|
159.
|
原著(症例報告除く)
|
基礎から臨床へ 内臓痛の分子機構 2000/06
|
160.
|
原著(症例報告除く)
|
最新の生化学研究 安全なアスピリン 選択的COX-2阻害薬 2000/05
|
161.
|
総説
|
【プロスタグランディンと病態】 プロスタグランディンと痛覚修飾 2000/04
|
162.
|
総説
|
【基礎麻酔学セミナー】 痛みの伝達機構 2000/03
|
163.
|
原著(症例報告除く)
|
Central roles of nociceptin/orphanin FQ and nocistatin: Allodynia as a model of neural plasticity 2000
|
164.
|
原著(症例報告除く)
|
Characterization of nociceptin/orphanin FQ-induced pain responses in conscious mice: Neonatal capsaicin treatment and N-methyl-D-aspartate receptor GluRε subunit knockout mice 2000
|
165.
|
原著(症例報告除く)
|
Close kinship of human 20α-hydroxysteroid dehydrogenase gene with three aldo-keto reductase genes 2000
|
166.
|
原著(症例報告除く)
|
Effect of intrathecal nocistatin on the formalin-induced pain in mice versus that of nociceptin/orphanin FQ 2000
|
167.
|
原著(症例報告除く)
|
Enhancement of dedifferentiation and myoid differentiation of retinal pigment epithelial cells by platelet derived growth factor 2000
|
168.
|
原著(症例報告除く)
|
Heterogeneity in ornithine cytotoxicity of bovine retinal pigment epithelial cells in primary culture 2000
|
169.
|
原著(症例報告除く)
|
Hypoxia and heat inhibit inducible nitric oxide synthase gene expression by different mechanisms in rat hepatocytes 2000
|
170.
|
原著(症例報告除く)
|
Nocistatin: A novel neuropeptide encoded by the gene for the nociceptin/orphanin FQ precursor 2000
|
171.
|
総説
|
一酸化窒素の光と影 1999/12
|
172.
|
総説
|
【NOと治療薬】NOと抗炎症薬 1999/09
|
173.
|
総説
|
アロディニアとそのメカニズム 1999/09
|
174.
|
総説
|
【痛みと鎮痛の分子メカニズム】痛みの分子機構とGenetic Pharmacology 1999/07
|
175.
|
原著(症例報告除く)
|
Involvement of primary afferent C-fibres in touch-evoked pain (allodynia) induced by prostaglandin E2 1999/06
|
176.
|
総説
|
ニューロサイエンスのNew Wave 新規痛覚制御ペプチド・ノシスタチン 1999/06
|
177.
|
総説
|
痛みの生化学 1999/01
|
178.
|
原著(症例報告除く)
|
cDNA cloning, expression and characterization of human prostaglandin F synthase 1999
|
179.
|
原著(症例報告除く)
|
Cloning and characterization of two novel aldo-keto reductases (AKR1C12 and AKR1C13) from mouse stomach 1999
|
180.
|
原著(症例報告除く)
|
Identification of human, rat and mouse nocistatin in brain and human cerebrospinal fluid 1999
|
181.
|
原著(症例報告除く)
|
Immunosuppressant FK506 inhibits inducible nitric oxide synthase gene expression at a step of NF-κB activation in rat hepatocytes 1999
|
182.
|
原著(症例報告除く)
|
Inhibition of iNOS induction by FK506, but not by cyclosporine, in rat hepatocytes 1999
|
183.
|
原著(症例報告除く)
|
Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice 1999
|
184.
|
総説
|
痛みの制御- ノシセプチンとノシスタチン- 1998/08
|
185.
|
原著(症例報告除く)
|
網膜色素上皮細胞におけるコラーゲン合成阻害の影響 1998/06
|
186.
|
原著(症例報告除く)
|
痛みのシンポジウム 脊髄におけるallodyniaの発現機序 1998/04
|
187.
|
原著(症例報告除く)
|
Anti-nociceptive responses produced by human putative counterpart of nocistatin 1998
|
188.
|
原著(症例報告除く)
|
Epidermal growth factor stimulates the recovery of glucose absorption after small bowel transplantation 1998
|
189.
|
原著(症例報告除く)
|
Expression of murine novel zinc finger proteins highly homologous to Drosophila ovo gene product in testis 1998
|
190.
|
原著(症例報告除く)
|
Interleukin 1β and interleukin 6, but not tumor necrosis factor α, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes 1998
|
191.
|
その他
|
Nocistatin reverses nociceptin inhibition of glutamate release from rat brain slices. 1998
|
192.
|
原著(症例報告除く)
|
Nocistatin, a peptide that blocks nociceptin action in pain transmission 1998
|
193.
|
原著(症例報告除く)
|
Prevention of ornithine cytotoxicity by proline in human retinal pigment epithelial cells 1998
|
194.
|
原著(症例報告除く)
|
Stimulation of nitric oxide release from rat spinal cord prostaglandin E2 1998
|
195.
|
原著(症例報告除く)
|
Synergistic regulation of inducible nitric oxide synthase gene by CCAAT/enhancer-binding protein β and nuclear factor-κB in hepatocytes 1998
|
196.
|
総説
|
ノシセプチンとノシスタチン 痛みの制御をめぐって 1998
|
197.
|
総説
|
慢性痛の発現機構の解明 1997/08
|
198.
|
原著(症例報告除く)
|
Characterization of nociceptin hyperalgesia and allodynia in conscious mice 1997/06
|
199.
|
総説
|
脊髄におけるhyperalgesiaの発現機序 最近の新しい知見 1997/03
|
200.
|
原著(症例報告除く)
|
Absence of prostaglandin E2-induced hyperalgesia in NMDA receptor ε subunit knockout mice 1997
|
201.
|
原著(症例報告除く)
|
Genomic organization and characterization of the gene encoding bovine prostaglandin F(2α) receptor 1997
|
202.
|
原著(症例報告除く)
|
Hepatocyte growth factor (HGF) stimulates lipid metabolism in rat hepatocytes 1997
|
203.
|
原著(症例報告除く)
|
Inhibition of nociceptin-induced allodynia in conscious mice by prostaglandin D2 1997
|
204.
|
原著(症例報告除く)
|
Involvement of prostaglandin E2 in rabbit corneal injury by anterior segment ischaemia 1997
|
205.
|
原著(症例報告除く)
|
The anti-inflammatory drug sodium salicylate inhibits nitric oxide formation induced by interleukin-1β at a translational step, but not at a transcriptional step, in hepatocytes 1997
|
206.
|
総説
|
脊髄におけるallodyniaおよびhyperalgesiaの発現機序 1997
|
207.
|
原著(症例報告除く)
|
Identification and characterization of an endogenous ligand for opioid receptor homologue ROR-C: Its involvement in allodynic response to innocuous stimulus 1996/12
|
208.
|
その他
|
プロスタグランジンの生殖生理に関する研究 1996/12
|
209.
|
総説
|
痛みとプロスタグランジン アロディニアの発生機序 1996/12
|
210.
|
原著(症例報告除く)
|
Hormonal regulation of prostaglandin F2 alpha receptor gene expression in mouse
ovary 1996/10
|
211.
|
総説
|
アロディニアの発現機序 1996/08
|
212.
|
原著(症例報告除く)
|
A possible mechanism for the stimulation of metalloproteinase production in human aortic intimal smooth muscle cells by linoleic acid hydroperoxide 1996
|
213.
|
原著(症例報告除く)
|
Characterization of prostaglandin F(2α) production in pregnant and cycling mice 1996
|
214.
|
原著(症例報告除く)
|
High-density lipoprotein inhibits the synthesis of platelet-activating factor in human vascular endothelial cells 1996
|
215.
|
原著(症例報告除く)
|
Hormonal regulation of prostaglandin F(2α) receptor gene expression in mouse ovary 1996
|
216.
|
原著(症例報告除く)
|
Interleukin 1β markedly stimulates nitric oxide formation in the absence of other cytokines or lipopolysaccharide in primary cultured rat hepatocytes but not in Kupffer cells 1996
|
217.
|
原著(症例報告除く)
|
Involvement of Glutamate Receptors in Strychnine- and Bicuculline-induced Allodynia in Conscious Mice 1996
|
218.
|
原著(症例報告除く)
|
PLD activation in Chinese hamster ovary (CHO) cells transfected with PGF2α receptor cDNA 1996
|
219.
|
原著(症例報告除く)
|
Prostaglandin D2 inhibits prostaglandin E2-induced allodynia in conscious mice 1996
|
220.
|
その他
|
Regulation of energy metabolism by interleukin-1β, but not by interleukin-6, is mediated by nitric oxide in primary cultured rat hepatocytes 1996
|
221.
|
原著(症例報告除く)
|
Suppression of prostaglandin E receptor signaling by the variant form of EP1 subtype 1996
|
222.
|
原著(症例報告除く)
|
プロスタグランジンとその周辺 V 痛みとプロスタグランジン 1995/02
|
223.
|
原著(症例報告除く)
|
Expression of mRNA encoding the prostaglandin F2 alpha receptor in bovine corpora
lutea throughout the oestrous cycle and pregnancy 1995/01
|
224.
|
その他
|
L-NAME, an inhibitor of nitric oxide synthase, blocks the established allodynia induced by intrathecal administration of prostaglandin E2. 1995
|
225.
|
原著(症例報告除く)
|
Molecular cloning and expression of a cDNA of the bovine prostaglandin F2 alpha
receptor 1995
|
5件表示
|
全件表示(225件)
|